Despite some obstructions, it is reported that the elevation of the von Willebrand factor happens not only in critically ill patients but in non‐critically ill COVID‐19 patients as well, and in consequence, there is a possibility of having high thromboembolic risks for both non‐critically along with critically ill COVID‐19 patients.256, 257. Here, VWF is linked to COVID-19.